| 영문 | receptor | 한글 | 수용체 |
|---|---|---|---|
| 설명 | 세포질내 또는 세포표면에 존재하는 분자구조로서 특이물질과 선택적으로 결합하며 결합에 의해 특이한 생리적 작용을 나타낸다. 펩티드호르몬, 신경전달물질, 항원, 보체, 면역글로불린에 대한 세포표면 수용체와 스테로이드에 대한 세포질내 수용체가 있다. |
||
| CDPS | calcium-dependent protease small subunit |
|---|---|
| FSV | feline fibrosarcoma virus; forward stroke volume; functional subunit |
| NFATp | pre-existing subunit of nuclear factor of activated T [cells] |
| SCN1A | sodium channel, neuronal alpha-subunit type 1 |
| SU | salicyluric acid; secretory unit; sensation unit; solar urticaria; sorbent unit; spectrophotometric ... |
| alpha1,3GT | Alpha1,3-galactosyltransferase |
|---|---|
| alpha1-ARs | Alpha1-adrenergic receptors |
| alpha1-AR | Alpha1-adrenoceptor |
| GFRalpha1 | GDNF Family Receptor alpha1 |
| AR | Alpha1-adrenergic receptors |
| alpha1-2,alpha1-3,alpha1-6-mannosidase | <enzyme> From rat liver; releases alpha1-2, alpha1-3, alpha1-6 linked residues from oligosaccharide substrates; end product of reaction is manalpha1-3(manalpha1-6)manbeta1-4glcnac; mw 110 kD; inhibited by edta, zn++ and cu++, swainsonine and 1-deoxymannojirimycin Registry number: EC 3.2.1.- Synonym: 2,3,6-alpha-mannosidase (26 Jun 1999) |
|---|---|
| gamma subunit, cGMP phosphodiesterase | <enzyme> Isolated from canine retinal rod photoreceptor cells; genbank u49359 Registry number: EC 3.1.14.- Synonym: pde-gamma, pdegamma, cgmp-pde gamma subunit (26 Jun 1999) |
| glycoprotein hormones, alpha subunit | A non-covalently bound subunit of the glycoprotein hormones tsh, fsh, lh, and hcg which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uraemia and malignant tumours. The alpha subunit may be involved directly in recognition of certain receptors. (12 Dec 1998) |
| ribulose-1,5-bisphosphate carboxylase-oxygenase large subunit epsilonN-methyltransferase | <enzyme> An aspect of EC 2.1.1.43; trimethylates lys-14 of rubisco Registry number: EC 2.1.1.- Synonym: rubisco lsmt, rubisco large subunit lysine n-methyltransferase (26 Jun 1999) |
| cholera toxin, B subunit-horseradish peroxidase | <chemical> Conjugate of horseradish peroxidase and cholera toxin Synonym: bhrp, horseradish peroxidase-cholera toxin b subunit, cholera toxin-horseradish peroxidase, horseradish peroxidase-cholera toxin, ib4-hrp (26 Jun 1999) |
| chorionic gonadotropin, beta subunit, human | The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (scan j clin lab invest suppl 1993;216:97-104) (12 Dec 1998) |
| phycocyanin alpha-subunit phycocyanobilin lyase | <enzyme> Cleaves thioether bond attaching phycocyanobilin to the alpha subunit of phycocyanin; product of the cpce and cpcf genes of synechococcus Registry number: EC 4.4.- Synonym: phycocyanobilin lyase (26 Jun 1999) |
| phycoerythrocyanin alpha-subunit phycobiliviolin lyase | <enzyme> Shows high degree of homology to phycocyanobilin lyase Registry number: EC 4.4.- Synonym: phycobiliviolin lyase, pece protein, pecf protein, pec alpha-subunit phycobiliviolin lyase (26 Jun 1999) |
| signal peptide p25-subunit IV cytochrome oxidase | <chemical> Similar in action to melittin Synonym: p25 presequence peptide-cytochrome oxidase, pre-ctox p25 (26 Jun 1999) |
| subunit | <cell biology> Components from which a structure is built, thus myosin has six subunits, microtubules are built of tubulin subunits. In some cases it may be more informative to speak of protomers. (06 Mar 1998) |
| subunit vaccine | <pharmacology> A vaccine composed of a purified antigenic determinant that is separated from the disease-causing organism. (06 Mar 1998) |
| acetylcholine receptor antibodies | <neurology, investigation> A test used to measure the amount of antibodies to acetylcholine receptors on nerve endings. This is a diagnostic test for myasthenia gravis. A normal value is no antibodies in the bloodstream. Acetylcholine receptor (AChR) binding autoantibodies (i.e. Antibodies reactive with several epitopes other than the binding site for acetylcholine or alpha-bungarotoxin) are present in approximately 88% of patients with generalised myasthenia gravis, 70% of ocular myasthenia and in approximately 80% of myasthenia gravis in remission. Although serum concentrations of AChR binding autoantibodies do not in general correlate well with severity of weakness, there is typical decrease in concentration as weakness improves with immunosuppressive therapy. AChR blocking autoantibodies (i.e., antibodies reactive with the AChR binding site) are present in about 50% of patients with myasthenia gravis, 30% with ocular myasthenia gravis and 20% of myasthenia gravis in remission, AChR blocking autoantibodies are the only AChR autoantibodies present in about 1% of myasthenia gravis. AChR modulating autoantibodies (i.e., autoantibodies which cross-link AChRs and cause their removal from muscle membrane surfaces) are present in more than 90% of myasthenia gravis and occasionally are the only AchR autoantibodies detectable in mild, recent onset or ocular-restricted myasthenia gravis. Results for AChR modulating autoantibodies can be transiently false-positive due to curare-like drugs used during general anesthesia. AChR autoantibodies of one or more types are found in at least 80% of ocular myasthenia gravis. Although generally absent in neurological conditions other than myasthenia gravis(and consequently unlikely to cause confusion in neurodiagnosis), false-positive results for AChR autoantibodies occasionally occur in primary biliary cirrhosis, tardive dyskinesia, autoimmune thyroiditis, the elderly, amyotrophic lateral sclerosis patients treated with cobra venom and patients with thymoma in the absence of myasthenia gravis. Approximately 1% of patients with rheumatoid arthritis treated with D-penicillamine develop AChR autoantibodies and myasthenia gravis, both of which disappear when the drug is discontinued. Babies born to ~10% of myasthenia gravis mothers have a transient neonatal form of myasthenia gravis that responds well to anticholinesterase therapy and usually remits within 1 month as maternal IgG disappears. (29 Dec 1997) |
| amino acid receptor | <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor. (18 Nov 1997) |
| AMPA receptor | <cell biology> Glutamate operated ion channel. See: excitatory amino acid receptor channels. (05 Feb 1998) |
| ANP receptor | <molecular biology> Family of 3 receptors for atrial natriuretic peptide. ANP A and ANP B have intracellular guanylate cyclase and protein kinase like domains. ANP C, shares the extracellular ligand binding and transmembrane domains, but lacks the functional intracellular domains and is not thought to be involved in signal transduction. (18 Nov 1997) |
Synonyms : CD213a1 Antigen, IL-13Ralpha1, Interleukin-13 Receptor alpha1 Chain, Antigen, CD213a1, Antigens, CD213a1, CD213a1, Antigens, Interleukin 13 Receptor alpha1 Chain, Interleukin 13 Receptor alpha1 Subunit, Interleukin 4, 13 Receptor Shared Subunit
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|